Chemoinformaics analysis of 31-NOR-7-LANOSTEROL ACETATE
| Molecular Weight | 456.755 | nRot | 6 |
| Heavy Atom Molecular Weight | 404.339 | nRig | 21 |
| Exact Molecular Weight | 456.397 | nRing | 4 |
| Solubility: LogS | -7.153 | nHRing | 0 |
| Solubility: LogP | 8.183 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 85 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 31 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 88.0472 |
| nHD | 0 | BPOL | 54.7708 |
| QED | 0.227 |
| Synth | 4.435 |
| Natural Product Likeliness | 3.141 |
| NR-PPAR-gamma | 0.168 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.273 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.836 |
| MDCK | 0.00000816 |
| BBB | 0.736 |
| PPB | 1.00336 |
| VDSS | 1.771 |
| FU | 0.0152221 |
| CYP1A2-inh | 0.034 |
| CYP1A2-sub | 0.375 |
| CYP2c19-inh | 0.098 |
| CYP2c19-sub | 0.957 |
| CYP2c9-inh | 0.095 |
| CYP2c9-sub | 0.591 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.237 |
| CYP3a4-inh | 0.305 |
| CYP3a4-sub | 0.634 |
| CL | 5.114 |
| T12 | 0.008 |
| hERG | 0.008 |
| Ames | 0.012 |
| ROA | 0.067 |
| SkinSen | 0.037 |
| Carcinogencity | 0.018 |
| EI | 0.027 |
| Respiratory | 0.97 |
| NR-Aromatase | 0.542 |
| Antiviral | No |
| Prediction | 0.641256 |